|
|
||||||||
Journal of Applied Physiology, Vol 67, Issue 1 357-365, Copyright © 1989 by American Physiological Society
ARTICLES |
R. J. King, J. J. Coalson, J. J. Seidenfeld, A. R. Anzueto, D. B. Smith and J. I. Peters
Department of Physiology, University of Texas Health Science Center, San Antonio.
Pulmonary surfactant was isolated from the lavage fluids of animals during the course of exposure to 100% O2, 80% O2, 40% O2, or 80% O2 plus 10(8) Pseudomonas aeruginosa instilled intratracheally and analyzed for its phospholipid composition. After 4-5 days of exposure to 100% O2, disaturated phophatidylcholine (DSPC) decreased to 87% of control, whereas the ratio of phosphatidylglycerol to phosphatidylinositol (PG/PI) was 37% of control. Longer periods of ventilation with 100% O2 resulted in DSPC falling to less than 40% of control. The injury was not reversed by reducing the O2 to 50%; rather, a progressive deterioration ensued. Acute respiratory failure (ARF) induced by 5 days of bacterial infection was very similar to that seen after 5 days of exposure to 100% O2. Ventilation with 80% O2 for 6 days resulted in smaller changes in DSPC but with differences in PG/PI comparable to those seen with 100% O2 or infection. We conclude that the ability of the type II cell to synthesize surfactant of normal composition is significantly impaired in these models of ARF. The earliest index of biochemical modification is the substantial change in PG/PI, which may be predictive of early lung injury. Further exacerbation of the injury could result in the reduction of DSPC content, with subsequent changes in lung mechanics and gas exchange.
This article has been cited by other articles:
![]() |
F. C. Henderson, O. L. Miakotina, and R. K. Mallampalli Proapoptotic effects of P. aeruginosa involve inhibition of surfactant phosphatidylcholine synthesis J. Lipid Res., October 1, 2006; 47(10): 2314 - 2324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vivekananda, D. Smith, and R. J. King Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L98 - L107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Awasthi, J. Vivekananda, V. Awasthi, D. Smith, and R. J. King CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-{alpha}, p38 MAPK, cPLA2, and 5-lipoxygenase Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L108 - L118. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Simonson, K. E. Welty-Wolf, Y.-C. T. Huang, D. E. Taylor, S. P. Kantrow, M. S. Carraway, J. D. Crapo, and C. A. Piantadosi Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry J Appl Physiol, August 1, 1997; 83(2): 550 - 558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |